Emilia Krol, MD
Vascular Surgery · Rock Hill, SCNPI 1952531386
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,749 of the $9,623 with a category attached, or 70.1%. Medtronic accounts for 71.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $3,051 and has fallen 70.0% since, to $915 in 2025.
Across 115 payments — averaging $83.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$7K
- Abbott$868
- Inari Medical, Inc.$578
- Silk Road Medical, Inc.$287
- Integra Lifesciences Corporation$270
- Bard Peripheral Vascular, Inc.$110
- plus $640 from 14 others
What the payments were for
- Travel & lodging$2,72728%
- Food & beverage$6,74970%
- Other$1472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 76 | $6,870 |
| Abbott | 10 | $868 |
| Inari Medical, Inc. | 3 | $578 |
| Silk Road Medical, Inc. | 3 | $287 |
| Integra Lifesciences Corporation | 3 | $270 |
| Bard Peripheral Vascular, Inc. | 3 | $110 |
| Cook Medical LLC | 3 | $105 |
| Terumo Medical Corporation | 1 | $98 |
| Endologix LLC | 1 | $87 |
| Johnson & Johnson | 1 | $76 |
| Penumbra, Inc. | 1 | $65 |
| Stryker | 1 | $40 |
| Medistim USA, Inc. | 1 | $31 |
| My01 Inc. | 1 | $30 |
| Boston Scientific | 2 | $26 |
| Misonix Inc | 1 | $19 |
| Philips North America LLC | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Bolton Medical Inc | 1 | $14 |
| Angiodynamics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Endurant$1,878
- Valiant Captivia$1,504
- ENDURANT IIS$850
- Supera peripheral stent system$562
- FlowTriever$392
- ClotTriever$392
- FLOWTRIEVER CATHETER, S$187
- CT THROMBECTOMY SYSTEM KIT$187
- ENROUTE Transcarotid Neuroprotection System$170
- ENROUTE Transcarotid Stent System$170
- ENHANCE Transcarotid Peripheral Access Kit$170
- ENROUTE 0.014 Guidewire$170
- ACell$147
How this compares
$9,623 in reported general payments places this provider in the 60th percentile of 99 vascular surgery providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 11 | $9,990 |
| ClopidogrelClopidogrel Bisulfate | 18 | $396 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $76 | $9,99011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 99 vascular surgery providers in South Carolina.
Other vascular surgery in Rock Hill
- Daniel McDevittRock Hill$52K
- Elias ArbidRock Hill$19K
- Patrick DuffyRock Hill$12K
- Michael NaylorRock Hill$7K
- John RossOrangeburg$847K
- David DeatonColumbia$609K
- Mathew WoosterWest Columbia$443K
- Sagar GandhiGreenville$236K
- Ravi VeeraswamyCharleston$164K
- Gerald FortunaWest Columbia$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.